Commonwealth Equity Services LLC Boosts Stock Position in DENTSPLY SIRONA Inc. $XRAY

Commonwealth Equity Services LLC lifted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 38.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 804,934 shares of the medical instruments supplier’s stock after purchasing an additional 223,339 shares during the quarter. Commonwealth Equity Services LLC owned about 0.40% of DENTSPLY SIRONA worth $10,215,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Bank of Montreal Can lifted its holdings in DENTSPLY SIRONA by 8.2% in the second quarter. Bank of Montreal Can now owns 352,524 shares of the medical instruments supplier’s stock valued at $5,598,000 after acquiring an additional 26,610 shares during the period. CWM LLC lifted its stake in shares of DENTSPLY SIRONA by 84.3% in the 3rd quarter. CWM LLC now owns 420,470 shares of the medical instruments supplier’s stock valued at $5,336,000 after purchasing an additional 192,373 shares during the period. Envestnet Portfolio Solutions Inc. lifted its stake in shares of DENTSPLY SIRONA by 36.9% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 15,460 shares of the medical instruments supplier’s stock valued at $246,000 after purchasing an additional 4,165 shares during the period. AGF Management Ltd. boosted its holdings in DENTSPLY SIRONA by 29.6% during the second quarter. AGF Management Ltd. now owns 186,424 shares of the medical instruments supplier’s stock worth $2,960,000 after buying an additional 42,542 shares in the last quarter. Finally, Prudential Financial Inc. grew its position in DENTSPLY SIRONA by 67.9% during the second quarter. Prudential Financial Inc. now owns 1,158,415 shares of the medical instruments supplier’s stock valued at $18,396,000 after buying an additional 468,415 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Insider Transactions at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier sold 82,200 shares of the firm’s stock in a transaction on Monday, December 8th. The stock was sold at an average price of $11.14, for a total value of $915,708.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.52% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Mizuho set a $13.00 price objective on shares of DENTSPLY SIRONA in a research report on Friday, November 7th. UBS Group lowered their price target on DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating on the stock in a research report on Tuesday, October 28th. Evercore ISI dropped their price objective on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a report on Wednesday, October 8th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, October 8th. Finally, Wells Fargo & Company dropped their price target on shares of DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating on the stock in a research note on Friday, November 7th. Two research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus price target of $15.15.

DENTSPLY SIRONA Trading Up 2.4%

Shares of XRAY opened at $12.78 on Monday. The firm’s fifty day moving average is $11.32 and its two-hundred day moving average is $13.14. The stock has a market cap of $2.55 billion, a PE ratio of -2.89, a price-to-earnings-growth ratio of 0.99 and a beta of 1.00. The company has a quick ratio of 0.99, a current ratio of 1.47 and a debt-to-equity ratio of 1.36. DENTSPLY SIRONA Inc. has a 52-week low of $9.85 and a 52-week high of $20.59.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). The business had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.33 million. DENTSPLY SIRONA had a positive return on equity of 17.10% and a negative net margin of 24.34%.The business’s revenue was down 4.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.50 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. Research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 9th. Shareholders of record on Friday, December 26th were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, December 26th. This represents a $0.64 dividend on an annualized basis and a yield of 5.0%. DENTSPLY SIRONA’s payout ratio is -14.48%.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.